SARS News and Research

RSS

Celltrion announces key milestones in its efforts to fight COVID-19

Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic.

23 Mar 2020

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI Corporation announced today it has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.

23 Mar 2020

The COVID-19 vaccine pipeline

Major nations are in a race to make an effective vaccine that could help treat the novel coronavirus infection COVID-19. As hundreds of thousands are infected across the world and over sixteen thousand killed, the pandemic shows no signs of relenting.

23 Mar 2020

CDC launches coronavirus self-checker – an online triage system

The influx of new coronavirus disease (COVID-19) cases has overwhelmed healthcare systems across the globe, including the United States. The country has seen a sharp increase in its infection and death toll, prompting the U.S. Centers for Disease Control and Prevention (CDC) to launch an online triage system to help residents make decisions about seeking appropriate medical care.

23 Mar 2020

Behave or expect lockdown like Italy, UK warns

Governments across the globe need to impose strict measures to implement lockdowns and quarantine procedures to fight the coronavirus disease (COVID-19) outbreak. The United Kingdom has imposed social distancing guidance, but some are still not following it appropriately.

23 Mar 2020

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.

23 Mar 2020

Coronavirus & the 2nd generation NObreath update

COVID-19, more commonly referred to as Coronavirus, has become an increasing concern, especially in the world of medical devices.

From Bedfont® Scientific Ltd 23 Mar 2020

Coronavirus & Bedfont products update

COVID-19, more commonly referred to as Coronavirus, has become an increasing concern, especially in the world of medical devices.

From Bedfont® Scientific Ltd 23 Mar 2020

Three doctors succumb to coronavirus as Philippines scrambles to trace 215 people

The Philippines has reported a sharp increase in confirmed cases of the coronavirus disease (COVID-19), with the death toll now at 33. The country has also seen the fall of front liner health workers amid the coronavirus fight, with three doctors succumbing to the infection.

23 Mar 2020

Lockdowns not enough to combat coronavirus, WHO warns

With more than 336,000 confirmed cases and at least 14,600 deaths across the globe, many countries and regions have imposed lockdowns in their territories to stem the spread of the coronavirus. The World Health Organization (WHO), however, says it is not enough.

23 Mar 2020

New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries

It is now abundantly clear that COVID-19 is not "just the flu" as Italy grapples to contain the virus. The country has taken surpassed the death toll of China since it recorded 5,476 deaths with a fatality rate of 8.3 percent. China has first shown a fatality rate of 2 to 3.4 percent, but a new study shows that the rate is lower than previously known.

22 Mar 2020

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

The virus that causes COVID-19 remains for several hours to days on surfaces and in aerosols, a new study published in the New England Journal of Medicine found.

22 Mar 2020

New European case registry to collect clinical data of patients with SARS-CoV-2 infection

When do patients infected with the new coronavirus develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now?

21 Mar 2020

Researchers decode 3D architecture of SARS-CoV-2 main protease

Teams around the world are working hard to develop active substances against SARS-CoV-2. The structural analysis of functional proteins of the virus is very helpful for this goal. The function of a protein is closely related to its 3D architecture.

21 Mar 2020

MILabs enhances preclinical diagnostic U-CT system for COVID-19 research

Based on recent scientific research, diagnostic X-ray CT is able to detect COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), in individuals with high clinical suspicion of the virus -- even in cases with negative initial DNA tests.

20 Mar 2020

World’s fastest supercomputer identifies chemicals with potential to stop COVID-19

What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.

20 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Researchers invent portable AI device for flu and pandemic forecasting

University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends.

19 Mar 2020

Pets, the novel coronavirus and COVID-19 disease

Can dogs and other pets play a role in the transmission of the novel coronavirus? The question has surfaced after a Pomeranian in Hong Kong tested positive for the SARS-CoV-2 or the novel coronavirus last week.

19 Mar 2020

Lopinavir and ritonavir drug combo tested in severe COVID-19

Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, “A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19,” was published in the latest issue of the New England Journal of Medicine (NEJM).

19 Mar 2020

SARS News and Research

Celltrion announces key milestones in its efforts to fight COVID-19

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

The COVID-19 vaccine pipeline

CDC launches coronavirus self-checker – an online triage system

Behave or expect lockdown like Italy, UK warns

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Coronavirus & the 2nd generation NObreath update

Coronavirus & Bedfont products update

Three doctors succumb to coronavirus as Philippines scrambles to trace 215 people

Lockdowns not enough to combat coronavirus, WHO warns

New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

New European case registry to collect clinical data of patients with SARS-CoV-2 infection

Researchers decode 3D architecture of SARS-CoV-2 main protease

MILabs enhances preclinical diagnostic U-CT system for COVID-19 research

World’s fastest supercomputer identifies chemicals with potential to stop COVID-19

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

Researchers invent portable AI device for flu and pandemic forecasting

Pets, the novel coronavirus and COVID-19 disease

Lopinavir and ritonavir drug combo tested in severe COVID-19

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News